Home/Granules India/Kandiraju Rao
KR

Kandiraju Rao

Joint Managing Director & CEO

Granules India

Granules India Pipeline

DrugIndicationPhase
ADHD Drug (unspecified)Attention Deficit Hyperactivity DisorderANDA Tentative Approval
RifaximinAntibiotic (Gastrointestinal)Process Validation
Potassium Chloride TabletsElectrolyte SupplementANDA Approved
OTC Product (unspecified)Over-the-Counter MedicationANDA Approved